Im Cannabis Corp (NASDAQ:IMCC) — Market Cap & Net Worth
Market Cap & Net Worth: Im Cannabis Corp (IMCC)
Im Cannabis Corp (NASDAQ:IMCC) has a market capitalization of $1.35 Million ($1.35 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30306 globally and #6086 in its home market, demonstrating a -14.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Im Cannabis Corp's stock price $0.22 by its total outstanding shares 6223323 (6.22 Million). Review Im Cannabis Corp total liabilities to assess the company's total debt and financial obligations.
Im Cannabis Corp Market Cap History: 2020 to 2026
Im Cannabis Corp's market capitalization history from 2020 to 2026. Data shows change from $2.91 Billion to $1.35 Million (-65.61% CAGR).
Index Memberships
Im Cannabis Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.00% | #899 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2856 of 3165 |
Weight: Im Cannabis Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Im Cannabis Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Im Cannabis Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Im Cannabis Corp's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.91 Billion | $15.89 Million | -$28.70 Million | 183.29x | N/A |
| 2021 | $1.25 Billion | $34.05 Million | -$17.76 Million | 36.62x | N/A |
| 2022 | $36.40 Million | $54.34 Million | -$188.89 Million | 0.67x | N/A |
| 2023 | $13.33 Million | $48.80 Million | -$9.50 Million | 0.27x | N/A |
| 2024 | $14.51 Million | $54.03 Million | -$10.59 Million | 0.27x | N/A |
| 2025 | $8.65 Million | $54.73 Million | -$11.32 Million | 0.16x | N/A |
Competitor Companies of IMCC by Market Capitalization
Companies near Im Cannabis Corp in the global market cap rankings as of June 18, 2026.
Key companies related to Im Cannabis Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #631 globally with a market cap of $43.86 Billion USD ( CN¥299.75 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.27 |
| #631 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.86 Billion | CN¥46.99 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Im Cannabis Corp Historical Marketcap From 2020 to 2026
Between 2020 and today, Im Cannabis Corp's market cap moved from $2.91 Billion to $ 1.35 Million, with a yearly change of -65.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.35 Million | -84.39% |
| 2025 | $8.65 Million | -40.37% |
| 2024 | $14.51 Million | +8.83% |
| 2023 | $13.33 Million | -63.38% |
| 2022 | $36.40 Million | -97.08% |
| 2021 | $1.25 Billion | -57.18% |
| 2020 | $2.91 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Im Cannabis Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.35 Million USD |
| MoneyControl | $1.35 Million USD |
| MarketWatch | $1.35 Million USD |
| marketcap.company | $1.35 Million USD |
| Reuters | $1.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Im Cannabis Corp
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.